-
MYC Inhibition By Omomyc Causes DNA Damage And Overcomes PARPi Resistance In Breast Cancer.
Study
EGAS50000001347
-
Dynamics of Tumor Heterogeneity from Primary to Metastatic Dissemination in Prostate Cancer
Study
EGAS50000000524
-
Genomic Data from Patients with Advanced Rare Cancers Treated with Pembrolizumab
Study
EGAS50000001508
-
Transcriptomic Data from Patients with Advanced Rare Cancers Treated with Pembrolizumab
Study
EGAS50000001509
-
Genomic and Transcriptomic Data from Advanced Rare Cancer Patients Treated with Pembrolizumab
Dataset
EGAD50000002182
-
MD Anderson Data Access Committee: Pembrolizumab in Advanced Rare Cancers
Dac
EGAC50000000860
-
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS50000000106
-
Comprehensive genetic landscape, immune checkpoint profiling, and establishment of patient-derived xenograft (PDX) of metachronous brain tumors from constitutive mismatch repair deficiency with a biallelic variant on MSH6
Study
EGAS50000000351
-
A 3D genome atlas of breast cancer progression (BRCA3D)
Study
EGAS50000000444
-
SickKids_Cancer Molecular Diagnostics
Dac
EGAC50000000375
-
NeoRhea Bulk RNA and Single nuclei RNA & ATAC
Study
EGAS50000001403
-
Distinct genomic profiles and clinical outcomes in constitutional mismatch repair deficiency-associated high-grade gliomas: insights into mutational signatures and clonal evolution
Study
EGAS50000001506
-
Whole-exome sequencing and RNA-seq data of paired normal-tumour samples from MMR-proficient early-onset colorectal cancer patients
Study
EGAS50000001296
-
Whole-exome sequencing and RNA-seq of paired normal-tumour samples from MMR-proficient early-onset colorectal cancer patients
Dataset
EGAD50000001844
-
Pan Prostate Cancer Group Data Access Control Committee
Dac
EGAC50000000602
-
Early-onset Colorectal Cancer Study TOGETHER Data Access Committee
Dac
EGAC50000000752
-
ctDNA Quantification in Blood Plasma Using Deep Learning Based Fragle Tool
Study
EGAS50000000122
-
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
Study
EGAS50000001469
-
Fragmentomics analyses of urinary cfDNA for urologic cancers
Dataset
EGAD50000002068
-
Transcriptomic profiling of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures
Study
EGAS00001004770
-
3D chromatin analysis of clear cell renal cell carcinoma using micro-C
Study
EGAS50000001323
-
Chromatin accessibility of clear cell renal cell carcinoma
Study
EGAS50000001325
-
Gene expression analysis of clear cell renal cell carcinoma
Study
EGAS50000001324
-
TONIC-Trial-cfDNA-Project
Study
EGAS50000001308
-
Oropharynx cancers sequencing study (RNA-seq from FFPE)
Study
EGAS50000000893
-
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
Study
EGAS50000001272
-
Clinical validity of post-surgery circulating tumor DNA (ctDNA) in stage III colon cancer patients treated with adjuvant chemotherapy: the PROVENC3 study
Study
EGAS50000000804
-
BCAC TIIC Data
Study
EGAS50000001477
-
BCAC TIIC data
Dataset
EGAD50000002125
-
Breast Cancer Association Consortium Data Access Coordinating Committee
Dac
EGAC50000000824
-
Integrative analysis of small cell lung cancer
Study
EGAS00001000299
-
RNA_sequencing
Study
EGAS00001000310
-
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations
Study
EGAS00001004940
-
Chordoma_Sequencing_Project_Whole_Genome
Study
EGAS00001000409
-
Matched_Pair_Cell_Line_Tumour_RNAseq
Study
EGAS00001000434
-
Copy number and mutation profiling of Stage 1 epithelial ovarian cancer biopsies
Study
EGAS00001004961
-
Psoriatic_arthritis
Study
EGAS00001002104
-
Nuclear_single_seq_pilot
Study
EGAS00001003386
-
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Study
EGAS00001000579
-
Osteosarcoma_RNAseq
Study
EGAS00001000615
-
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Study
EGAS00001000650
-
Feasibility and safety of a multi-cancer blood test for screening and intervention
Study
EGAS00001004372
-
An oncogenic enhancer-rearrangement causes concomitant deregulation of EVI1 and GATA2 in leukemia. Targeted resequencing of chromosomal regions centered on 3q21 and 3q26 in conjunction with RNA-Seq from Acute Myeloid Leukemia patients.
Study
EGAS00001000669
-
Whole exome sequencing from early stage non-small cell lung cancer patients at MDACC
Study
EGAS00001004026
-
Whole genome bisulfite sequencing of hepatitis B virus-associated hepatocellular carcinoma tumor and non-cancerous samples
Study
EGAS00001002230
-
Large scale familial CRC exome sequencing study
Study
EGAS00001001666
-
Pediatric tumor in a single child of three large nuclear families
Study
EGAS00001005321
-
Burden_of_Disease_in_Sarcoma
Study
EGAS00001000087
-
Testing_the_feasibility_of_genome_scale_sequencing_in_routinely_collected_FFPE_cancer_specimens_versus_matched_fresh_frozen_samples
Study
EGAS00001000173
-
Organoid_Derivation_Project__TGS
Study
EGAS00001002221